Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

13.67
-0.4500-3.19%
Post-market: 13.41-0.2600-1.90%17:20 EDT
Volume:1.20M
Turnover:16.48M
Market Cap:1.19B
PE:-7.31
High:14.13
Open:13.75
Low:13.34
Close:14.12
52wk High:36.26
52wk Low:2.86
Shares:87.16M
Float Shares:71.89M
Volume Ratio:0.45
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8700
EPS(LYR):-1.8700
ROE:-36.61%
ROA:-21.42%
PB:2.49
PE(LYR):-7.31

Loading ...

Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 23, 2023

Major Issues Report

Form 8-K - Current report
Oct 19, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Oct 17, 2023

Major Issues Report

Form 8-K - Current report
Oct 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 20, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 14, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 14, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Sep 05, 2023

Major Issues Report

Form 8-K - Current report
Sep 05, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities